Latest Administration News

Actinogen Medical has obtained positive scientific advice from the European Medicines Agency that aligns with prior FDA guidance, clarifying regulatory requirements for its Alzheimer’s drug Xanamem and paving the way for a streamlined approval process in major markets.

The Therapeutic Goods Administration has broadened the range of clinicians eligible to participate in psychedelic-assisted psychotherapy, a move set to speed up recruitment and improve patient access across Emyria’s national Empax network.

EV Resources has cleared a critical regulatory hurdle by obtaining the Change of Use of Soil permit for its Tecomatlán Plant, enabling the final environmental report filing and grid connection application that pave the way for near-term antimony production.

Sunshine Metals has secured $7.7 million through an oversubscribed Share Purchase Plan, exceeding its $3 million target, to fund the Mt Moss processing facility acquisition and Liontown mine start-up.

Osmond Resources has unveiled new channel sample assays from Spain’s Orión project, revealing outstanding heavy mineral grades that strengthen the case for its maiden Mineral Resource Estimate. Phase 2 drilling is poised to start pending final approvals, while a Scoping Study advances towards completion in late 2026.

Xingye Gold (Hong Kong) Mining Company Limited has launched an off-market takeover offer for all remaining shares in Far East Gold Ltd (ASX:FEG) at $0.13 cash per share, offering shareholders a premium amid stalled projects and funding concerns.

Minbos Resources has secured a crucial milestone by signing the final security agreement for its US$16 million IDC loan and submitting a first drawdown request of US$4.8 million to fund ongoing construction at Cabinda.

Prodigy Gold’s scoping study for the Hyperion Gold Deposit confirms a viable open pit project with a 4-year mine life and strong financial metrics, underpinned by a 454,000-ounce resource.

Euro Manganese has cleared major regulatory hurdles for its Chvaletice Manganese Project, securing construction and land planning permits that significantly reduce project risk and pave the way for production in Europe’s only near-term high-purity manganese source.

DGR Global lodged a key director interest notice 14 days late due to an administrative slip, prompting an ASX compliance query. The company has outlined its existing governance measures and pledged refresher training to tighten disclosure controls.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Viridis Mining has produced its first batch of high-grade Mixed Rare Earth Carbonate at its Poços de Caldas Demonstration Plant, advancing key milestones for the Colossus Project and setting the stage for commercial-scale rare earth production.